We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
- Authors
Hira, S. K.; Feldblum, P. J.; Kamanga, J.; Mukelabai, G.; Weir, S. S.; Thomas, J. C.
- Abstract
We aimed to measure the effectiveness of latex condoms and of nonoxynol-9 [N-9] spermicides, in preventing HIV transmission in heterosexual serodiscordant couples in Lusaka. Each couple was examined at clinic visits scheduled at 3-month intervals for one year or more per couple, or until seroconversion or discontinuation. Couples were given condoms and their choice of 3 N-9 products and advised to use both at every intercourse. Sexual exposure was ascertained from coital logs that recorded coitus and barrier method use. HIV serological testing was done at each clinic visit (ELISA and Western blot if positive). One hundred and ten discordant couples were followed for a mean of 17.6 months. Seventy-eight per cent of coital episodes were protected by condoms, 85% by spermicides and 6.4% were unprotected. Fourteen seroconversions occurred (8.7 infections per 100 couple-years [c-y]). The rate was higher among seronegative men than seronegative women. Among couples who reported using condoms at every intercourse the infection rate was 2.3/100 c-y, compared with 10.7/100 c-y among couples using condoms less consistently (rate ratio [RR] 0.2; 95% confidence interval [CI] 0-1.6). Among couples who reported using N-9 at every intercourse, the seroconversion rate was 6.9/100 c-y; among couples who reported less than full-time N-9 use, the rate was 8.9/100 c-y (RR 0.8; 95% CI 0.2-2.8). Among the subset of female seronegatives, the N-9 RR was 0.5 (95% CI 0.1-3.8). But when we calculated HIV rates according to N-9 consistency in coital acts when condoms were not used, there was no evidence of protection with higher N-9 use. Consistent use of latex condoms reduces the incidence of HIV infection, but the association between N-9 spermicides and HIV is less clear. The current study could not provide compelling data on the impact of N-9 spermicide use on risk of HIV infection. The study's small size, as well as the consistency of concurrent condom use, limited our inferences. Available spermicide products must be studied further.
- Subjects
ZAMBIA; CONDOMS; PREVENTION of sexually transmitted diseases; EQUIPMENT &; supplies; NONOXYNOL-9; HIV infections; HIV prevention; SURFACE active agents; SPERMICIDES; HIV infection epidemiology; CLINICAL trials; COMPARATIVE studies; ENZYME-linked immunosorbent assay; HIV; RESEARCH methodology; MEDICAL cooperation; RESEARCH; HUMAN sexuality; SEXUAL intercourse; VIRAL antibodies; WESTERN immunoblotting; EVALUATION research; DISEASE incidence; SEXUAL partners; HIV seronegativity; THERAPEUTICS
- Publication
International Journal of STD & AIDS, 1997, Vol 8, Issue 4, p243
- ISSN
0956-4624
- Publication type
journal article
- DOI
10.1258/0956462971919994